Llwytho...
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma
A differentiation antigen commonly expressed on melanoma cells, gp100 is the target of infiltrating T cells. We conducted a phase I randomized cross-over trial of melanoma patients with either xenogeneic (mouse) or human gp100 plasmid DNA injected intramuscularly at three dosages (100, 500 or 1,500 ...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , , , , , , , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Academy
of Cancer Immunology
2009
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2888533/ https://ncbi.nlm.nih.gov/pubmed/19496531 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|